1Dani JA. Overview of nicotinic receptors and their roles in the central nervous system. Biol Psychiatry, 2001, 49: 166-174.
2Mihailescu S, Drucker-Colyn R. Nicotine, brain nicotinic receptors, and neuropsychiatric disorders. Arch Med Res, 2000, 31: 131-144.
3Sihver W, Nordberg A, langstrom B. Ligands for in vivo imaging of nicotinic receptor subtypes in Alzheimer brain. Acta Neurol Scand, 2000, 176Suppl: 27-33.
4Brown-Proctor C, Snyder SE, Sherman PS, et al. Synthesis and in vivo evaluation of ( E)- N-^11 C-Methyl-4- ( 3-pyridinyl)-3-butene-1 -amine (^11 C-Metanicotine) as a nicotinic receptor radioligand. Nucl Med Biol, 2000,27: 415-418.
5Dolle F, Valette H, Hinnen F, et al. Synthesis and preliminary evaluation of a ^11 C labeled agonist of the α7 nicotinic acetylcholine receptor. J Labelled Comp Radiopharm, 2001, 44: 785-795.
6Fujita M, Seibyl JP, Vaupel DB, et al. Whole-body biodistribution, radiation absorbed dose, and brain SPET imaging with ^123I-5-I-A-85380 in healthy human subjects. Eur J Nucl Med Mol Imaging, 2002, 29: 183-190.
7Kimes AS, Horti AG, Contoreggi C, et al. Imaging human nicotinic receptors. Savannah, GA: Proceedings of the Society for Research on Nicotine & Tobacco, 2002.
8Gundisch D. Nicotinic acetylcholine receptors and imaging. Curt Pharm Des, 2000, 6: 1143-1157.
9Roger G, Lagnel B, Rouden J. Synthesis of a 2-pyridinyl-^18F-labeled fluoro derivative of ( - )-cytisine as a candidate radioligand for brain nicotinic α4β2 receptor imaging with PET. Bioorg Med Chem, 2003, 11: 5333-5343.
10Paterson D, Nordberg A. Nicotinic acetylcholine receptor and imaging.Prog Neurobiol, 2000, 61: 75-111.
